An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen

Name: An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen
License: Public Domain

Glaxo Wellcome

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

anti-hiv-agents hiv-infections na

hiv infections, hiv protease inhibitors, vx 478, anti-hiv agents, abacavir, interventional, na

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

An Open-Label Study to Evaluate the Efficacy and Safety of Amprenavir (141W94) and Abacavir Combination Therapy in Protease Inhibitor Experienced Subjects With HIV-1 Infection Who Are Failing Their Current Antiretroviral Treatment Regimen

Related documents